Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Sam Kwon
Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons
Highlights • Postmortem and iPSC-derived FTD neurons upregulate inflammatory genes, including SPP1 • FTD neurons show mitochondrial phenotypes partially rescued by SPP1 knockdown • Grafted FTD neurons show impaired cell survival and elevate reactive gliosis • Knockdown of SPP1 in FTD neurons improves engraftment and reactive gliosis Summary Frontotemporal dementia (FTD) is an incurable group of early-onset dementias that can be caused by the deposition of hyperphosphorylated tau in patient...
Effects of repeated developmental GLP-1R agonist exposure on adult behavior and hippocampal structure in mice
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome
Publication HistoryPublished online: May 05, 2017Accepted: March 28, 2017; Received in revised form: February 14, 2017; Received: October 14, 2016;
Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) - Lim - 2016 - Diabetes, Obesity and M
Gemigliptin is a new dipeptidyl peptidase-IV inhibitor. We investigated the efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes (T2D).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sam
Contact Sam, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack